These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34283701)

  • 1. Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.
    Adams ZW; Agley J; Pederson CA; Bell LA; Aalsma MC; Jackson T; Grant MT; Ott CA; Hulvershorn LA
    Subst Abus; 2022; 43(1):336-343. PubMed ID: 34283701
    [No Abstract]   [Full Text] [Related]  

  • 2. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
    Andraka-Christou B; Gabriel M; Madeira J; Silverman RD
    J Subst Abuse Treat; 2019 Sep; 104():72-82. PubMed ID: 31370988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
    Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
    PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.
    Donahoe JT; Donohue JM; Saloner BK
    JAMA Health Forum; 2024 Sep; 5(9):e242807. PubMed ID: 39240579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.
    Khatri UG; Howell BA; Winkelman TNA
    Health Aff (Millwood); 2021 Apr; 40(4):562-570. PubMed ID: 33819101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study.
    An Y; Hoffmann CJ; Bhoora U; Ndini P; Moyo D; Steiner L; Tshuma S; Mabuto T; Hugo J; Owczarzak J; Marcus TS
    Harm Reduct J; 2023 Jul; 20(1):90. PubMed ID: 37480041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.
    Howell BA; Puglisi L; Clark K; Albizu-Garcia C; Ashkin E; Booth T; Brinkley-Rubinstein L; Fiellin DA; Fox AD; Maurer KF; Lin HJ; McCollister K; Murphy S; Morse DS; Shavit S; Wang K; Winkelman T; Wang EA
    J Subst Abuse Treat; 2021 Sep; 128():108315. PubMed ID: 33583610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.
    Krawczyk N; Buresh M; Gordon MS; Blue TR; Fingerhood MI; Agus D
    J Subst Abuse Treat; 2019 Aug; 103():1-8. PubMed ID: 31229187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
    Cheng A; Badolato R; Segoshi A; McDonald R; Malone M; Vasudevan K; Badiei B; Sugarman A; Macdonald R; Mangat J; Giftos J; Lee JD; Tofighi B
    Addict Sci Clin Pract; 2022 Jan; 17(1):4. PubMed ID: 35093164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States.
    Sanmartin MX; McKenna RM; Ali MM; Krebs JD
    J Ment Health Policy Econ; 2020 Mar; 23(1):19-25. PubMed ID: 32458814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.
    Sugarman OK; Bachhuber MA; Wennerstrom A; Bruno T; Springgate BF
    PLoS One; 2020; 15(1):e0227968. PubMed ID: 31961908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
    Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
    Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
    Kennedy-Hendricks A; Bandara S; Merritt S; Barry CL; Saloner B
    Drug Alcohol Depend; 2021 Sep; 226():108881. PubMed ID: 34218008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.
    Finlay AK; Morse E; Stimmel M; Taylor E; Timko C; Harris AHS; Smelson D; Yu M; Blue-Howells J; Binswanger IA
    J Gen Intern Med; 2020 Sep; 35(9):2529-2536. PubMed ID: 32583337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System.
    Howell BA; Martin RA; Lebeau R; Truong AQ; Wang EA; Rich JD; Clarke JG
    Health Aff (Millwood); 2021 Aug; 40(8):1304-1311. PubMed ID: 34339247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.